Open Letter on Gene Drive Technology
Posted 5
To the Parties to the Convention on Biological Diversity and the Parties to the Cartagena Protocol on Biosafety:
We urge you to support ongoing and new gene drive research, building on cautious and responsible practices and broad stakeholder dialogue.
The potential for gene drive technology is very significant. It is a novel tool which may enable interventions that are durable, cost-effective, and highly efficacious, complementing existing efforts to improve human health and environmental sustainability.
We urge you to resist current advocacy efforts demanding a ban on gene drive research or on the future use of gene drive-based products. Imposing a moratorium on such promising life-saving and life-improving innovations so early in their development would be unwarranted, damaging and irresponsible. Blanket bans discourage research and prevent regulators, policy-makers and other stakeholders from having an informed conversation about the use of new technologies.
One potential application of gene drive is to reduce the burden of vector-borne diseases such as malaria, dengue and the Zika virus, which account for more than 17% of all infectious diseases, and cause more than 1 million deaths annually. The cost of such disease is tremendous: malaria alone is estimated to cost African countries USD $12 billion a year.
Other potential applications, such as for the control of invasive alien species for conservation purposes, are also being investigated. The total loss to the world economy as a result of invasive non-native species has been estimated at 5% of global annual production. Invasive species are the leading cause of island extinctions, and the second-leading cause of extinctions on continental mainlands.
Current research on gene drive is at an early stage, and so definitive decisions about gene drive-based products is premature at best. Based on current progress, products ready for field testing are 5 years out, possibly longer. This gives scientists and stakeholders, particularly those from countries where gene drives might one day be employed, time to consider the important questions of regulation, risk assessment, ethics, and engagement, and to prepare for assessing an actual application.
There are regulatory systems set up to rigorously assess new classes of medicines, new vaccines, new pesticides, and applications of living modified organisms, for risks and benefits on a case-by-case basis. A moratorium on the use of gene drive violates the case by case approach of these systems and risks closing the door on critical new tools.
We need research on gene drives that is careful, incremental, and independently vetted. There are already efforts underway to define frameworks for responsible research and use. Both the US National Academies of Sciences (NAS) and the UK House of Lords have recently published reports noting the great potential of gene drive research while also laying out principles for a safe and constructive path forward. The African Union has also mandated New Partnership for African Development (NEPAD) to seek expert views on emerging technologies, such as gene drive. These open consultative approaches are the best way forward and we urge Parties to the Convention to participate in future dialogues as a way to help build consensus.
We recognize that gene drive applications may work in some areas or for some applications, and not for others. We need the knowledge and understanding acquired through research and development to enable national authorities to engage in detailed case-by-case assessments of each application of gene drive technology.
We hope that you will express support in the upcoming MOP8 and COP13 for further research in this field and not make a foregone conclusion for or against this possible tool before its potential and risks can be appropriately evaluated.
Signed:
Prof. Austin Burt,
Professor of Evolutionary Genetics
Imperial College London
Principal Investigator, Target Malaria
Pf Andrea Crisanti
Professor of Molecular Parasitology
Imperial College London
Prof. Abdallah Daar
Professor of Clinical Public Health and Global Health
Dalla Lana School of Public Health
Professor of Surgery
University of Toronto
Dr. Fred Aboagye-Antwi
Lecturer in Medical Entomology and Parasitology
Department of Animal Biology and Conservation Science, School of Biological Sciences
College of Basic and Applied Sciences
University of Ghana
Prof. Traoré Sékou F.
Director of MRTC Entomology
FAPH – University of Sciences, Techniques and Technologies of Bamako, Mali
Dr Charles Mbogo
Chief Research Scientist
KEMRI- Wellcome Trust
President of the Pan African Mosquito Control Association (PAMCA)
Dr. Louis G. Mukwaya
Former Director of Research &
Former Asst.Director, Uganda National Health Research Organization (UVRI)
Prof. Paulo Paes de Andrade
Professor
Department of Genetics
Federal University of Pernambuco, Recife, Brazil
Prof Halidou Tinto, PharmD, PhD
Directeur de Recherche
Professeur de Parasitologie Associé à l’Univ de Bobo-Dioulasso
Directeur Régionale de l’IRSS du Centre-Ouest
Chevalier de l’Ordre des Plames Académiques
Dr. Athanase Badolo
Associate Professor of Medical Entomology
Department of Animal Biology and Ecology
Université Ouagadougo – Pr Joseph Ki-Zerbo
Burkina Faso
Prof. Dyann Wirth, Ph.D.
Richard Pearson Strong Professor and
Chair, Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health
Dr. Jonathan Kayondo
Ag. Head Entomology Department
Uganda Virus Research Institute
Principal Investigator, Target Malaria Uganda
Dr. Coulibaly Mamadou B.
Vector Biologist, Malaria Research & Training Center (MRTC)
University of Sciences, Techniques & Technologies of Bamako, Mali
Principal Investigator Target Malaria Mali
Dr. Stephen Higgs
Peine Professor of Biosecurity,
University Distinguished Professor, Diagnostic Medicine and Pathobiology, Kansas State University
Dr. George K. Christophides
Professor of Infectious Diseases and Immunity
Imperial College London
Prof. James P. Collins
Ullman Professor
Arizona State University/Tempe
Nora Besansky
O’Hara Professor of Biological Sciences
University of Notre Dame
Prof. Jim Lavery, Ph.D.
Hilton Chair in Global Health Ethics
Professor, Hubert Department of Global Health
Rollins School of Public Health
Emory University
Prof. Anthony A. James
Irvine
California
Dr. Jo Lines
Reader of Malaria Control and Vector Biology
London School of Tropical Hygiene and Medicine
Prof. Jake Tu
Professor
Dept. of Biochemistry
Virginia Tech
Prof. Azra Ghani
Chair in Infectious Disease Epidemiology
Faculty of Medicine, School of Public Health
Imperial College London
Prof. John Mumford
Professor of Natural Resource Management
Centre for Environmental Policy
Imperial College London
Zach N. Adelman
Associate Professor
Department of Entomology
Texas A&M University
Dr. Barry Stoddard
Member
Fred Hutchinson Cancer Research Center
Prof. Roberta Spaccapelo
Prof. of Microbiology
Department of Experimental Medicine
University of Perugia
Prof. Raymond J. Monnat, Jr.
Professor of Pathology/Genome Sciences
University of Washington
Dr. John Marshall
Assistant Professor in Residence
School of Public Health
University of California, Berkeley
Prof. Julian Kinderlerer
Immediate past President, European Group on Ethics
Emeritus Professor of IP Law, IP Law & Policy Research Unit, University of Cape Town
Former Professor of biotechnology & society, TU Delft
Prof. David Threadgill, PhD
Distinguished Professor
Director of the Texas A&M Institute of Genome Sciences and Society
Texas A&M University
Andrew Cox
CEO
Invasive Species Council
Australia
Prof. Kevin M. Esvelt
MIT Media Lab
Massachusetts Institute of Technology
Ryan Phelan
Executive Director and Co-founder
Revive & Restore
Prof. Bernie Tershy
Professor
Ecology and Evolutionary Biology
UC Santa Cruz
Dr. Maharaj Krishan Bhan
National Science Professor
Indian Institute of Technology, Delhi
David Hartwell
Vice chair
National Audubon
Prof. Laurie Zoloth, PhD.
President, Faculty Senate Northwestern University
A McCormick Professor, 2009
Director of Graduate Studies
Department of Religious Studies
Program in Jewish Studies
Program in Bioethics and Medical Humanities
Weinberg College of Arts and Sciences
Feinberg School of Medicine
Northwestern University
Dr. Paulina Tindana
Bioethicist
Senior Research Fellow, Navrongo Health Research Centre, Ghana
Dr. Thomas Maina Kariuki
Director
Alliance for Accelerating Excellence in Science in Africa
Fellow, African Academy of Sciences (AAS)
Dr. Karen Poiani
CEO
Island Conservation
Prof. Yeya Tiemoko Touré
Medical entomologist
Faculté de Médecine et d’odontostomatologie
Bamako, Mali
Dr. Daniel Masiga
Senior Scientist and Head of the Molecular Biology, Bioinformatics & Biostatistics Unit, ICIPE
Dr. Ouedraogo Sylvin
Directeur de l’Institut de Recherche en Sciences de la Sante (IRSS), Burkina Faso
Directeur de Recherche
Chevalier de l’Ordre des Palmes Academiques
Dr. Fredros Okumu, PhD
Director of Science
Ifakara Health Institute, Tanzania
Dr Jane Kengeya-Kayondo
Regional Coordinator, East & Southern Africa
Africa Research Excellence Fund
C/o Medical Research Council Unit on AIDS
Uganda Virus Research Institute
Dr. Pontiano Kaleebu
Acting Director, Uganda Virus Research Institute
Director, Medical Research Council – UVRI Uganda Research Unit on AIDS
Prof. Jerome Amir Singh
Director
Ethical, Legal, Social, Cultural Issues (ELSCI) Programme on Synthetic Biology Head of Ethics and Law, CAPRISA University of KwaZulu-Natal, Durban
South Africa
Prof. Margareth Capurro
Associate Professor
Department of Parasitology
University of Sao Paulo
Brazil
Prof. John Godwin, PhD
Professor of Biological Sciences,
North Carolina State University
Dr Dabire K Roch
Directeur Regionale de l’Institut de Recherche en Sciences de la Sante (IRSS)
Directeur de Recherche
Chevalier de l’Ordre des Palmes Academiques
Prof. Kevin Marsh
Professor of Tropical Medicine
University of Oxford
Senior Advisor, African Academy of Sciences
Dr Diabate Abdoulaye
Chef de Bureau liaison recherche développement de la Direction Régionale de l’Ouest de l’IRSS, Burkina Faso
Maitre de Recherche
Chevalier de l’Ordre des Palmes Académiques
Principal Investigator, Target Malaria Burkina Faso
Prof. Peter Agre, M.D.
Bloomberg Distinguished Professor and Director
Johns Hopkins Malaria Research Institute
Johns Hopkins Bloomberg School of Public Health
Prof. Ethan Bier
Professor, University of California, San Diego
Principle Investigator, Tata Institute for Active Genetics and Society
Dr. Claudia Emerson
Director, Institute on Ethics & Policy for Innovation
McMaster University
Dr. Andrew M. Scharenberg M.D.
Professor of Pediatrics
Adjunct Professor of Immunology
Co-director, Program in Cell and Gene Therapy
University of Washington School of Medicine
Seattle Children’s Research Institute
Dr. Allan Ronald
Distinguished Emeritus Professor
University of Manitoba
Prof. Steven Russell
Department of Genetics
University of Cambridge
Dr. Nicole L. Achee, PhD.
Principal Investigator
Spatial Repellents for Control of Vector-borne Disease
Prof. Paul Freemont
Head of the Section of Structural Biology Department of Medicine
Imperial College London
Prof. Charles Godfray
Hope Professor of Entomology, Department of Zoology
Oxford University
Project partner, Target Malaria
Prof. Omar S. Akbari, Ph.D.
Institute for Integrative Genome Biology
Center for Disease Vector Research
Department of Entomology
University of California, Riverside (UCR)
Greta Immobile Molaro
Chief Executive Officer
Polo d’Innovazione Genomica, Genetica e Biologia
Dr. Nikolai Windbichler
Research Fellow
Imperial College London
Dr. Philippos A. Papathanos
Section of Genomics and Genetics,
Department of Experimental Medicine
University of Perugia
Dr. David O’Brochta
Professor
University of Maryland College Park
Prof. Bruce A. Hay
Professor
Division of Biology and Biological Engineering
California Institute of Technology
Prof. Francesco Frati
Rector
University of Sienna, Italy
Dr. Jeremy Herren, PhD
Visiting Scientist
Emerging Infectious Disease Lab,
ICIPE
Donald Croll
Professor
Ecology and Evolutionary Biology
UC Santa Cruz
Stewart Brand
Co-founder
Revive & Restore
Dr. Douglas W. Miano
Senior Lecturer
Department of Plant Science and Crop Protection
University of Nairobi
Sir Brian Greenwood
Professor of Clinical Tropical Medicine
London School of Hygiene and Tropical Medicine
Prof Luke Alphey, PhD
The Pirbright Institute
Antoinette Piaggio, PhD
Molecular Ecologist
Dr. Evelyn Gitau, PhD
Programme Manager,
Alliance for Accelerating Excellence in Science in Africa
Grand Challenges Africa
Prof. Frederic Tripet
Professor in Medical and Molecular Entomology
Director Centre for Applied Entomology and Parasitology
Keele University
Mark Q. Benedict
Research Biologist
Atlanta, Georgia USA
Elizabeth Heitman, PhD
Program on Ethics in Science and Medicine
UT Southwestern Medical Center
Professor Steve Lindsay
Chair in Public Health Entomology
Durham University, UK
